Clinical Trials Browser

Completed × Sarcoma × regorafenib × Clear all

NCT03793361 2026-03-18

EREMISS

Phase 2 Completed

Sarcoma

NCT01900743 2026-03-13

REGO-SARC

Phase 2 Completed

Neoplasm Metastasis, Sarcoma

NCT02307500 2022-09-10

RESOUND

Phase 2 Completed

DermatologicGastrointestinalGynecologicSarcomaThoracic

Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Thymoma

NCT02048722 2022-04-25

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Phase 2 Completed

31 enrolled 15 charts

Hemangiosarcoma, Sarcoma